News

Filter

Current filters:

LyricaEli LillyResearch

1 to 9 of 96563 results

GlaxoSmithKline’s third-qtr results not as bad as expected

22-10-2014

UK pharma giant GlaxoSmithKline has reported a downturn in both sales and profits for the third quarter…

FinancialGlaxoSmithKlinePharmaceuticalViiV Healthcare

Tekmira starts manufacture of new RNAi therapeutic for Ebola

22-10-2014

Canadian RNA interference (RNAi) therapeutics developer Tekmira Pharmaceuticals says it has commenced…

Anti-viralsPharmaceuticalProductionResearchTekmira PharmaceuticalsTKM-Ebola

Janssen commits $200 million to speeding up Ebola vaccine development and increasing production

Janssen commits $200 million to speeding up Ebola vaccine development and increasing production

22-10-2014

US health care giant Johnson & Johnson is to commit up to $200 million to accelerate and expand the production…

Antibiotics and Infectious diseasesBavarian NordicBiotechnologyEuropeJanssenResearch

GW Pharmaceuticals granted orphan designation by the EMA for Epidiolex

GW Pharmaceuticals granted orphan designation by the EMA for Epidiolex

22-10-2014

Cannabinoid product specialist GW Pharmaceuticals has been granted orphan designation by the European…

CNS DiseasesepidiolexGW PharmaceuticalsPharmaceuticalResearchUSA

Actavis signs option to acquire relamorelin developer

22-10-2014

Ireland-headquartered Actavis has been granted an exclusive option to acquire USA-based biopharma company…

ActavisGastro-intestinalsMergers & AcquisitionsPharmaceuticalrelamorelinRhythm Health

New angel investment initiative to boost funding for UK bioscience businesses

New angel investment initiative to boost funding for UK bioscience businesses

22-10-2014

Emerging bioscience companies in the UK will have access to new sources of funding as a result of an…

FinancialLondon Business AngelsPharmaceuticalUKUnited Kingdom

Ferring Pharma regains rights to DDAVP portfolio

22-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says it has acquired DDAVP (desmopressin…

DiabetesGenito-urinaryLicensingPharmaceutical

aTyr Pharma appoints John McKew as vice president of research

22-10-2014

US rare disease company aTyr Pharma has named John McKew as vice president of research.

aTyrBiotechnologyBoardroomNational Institutes of HealthUSA

1 to 9 of 96563 results

Back to top